News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Fernandes Peter
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2023 |
4
| Fernandes Peter (See Remarks) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.8264, valued at
$82.6k
|
|
| 02/14/2023 |
4
| Fernandes Peter (CEO) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.52, valued at
$152k
|
|
| 12/13/2022 |
4
| Fernandes Peter (PRINCIPAL EXECUTIVE OFFICER) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 9,985 shares
@ $0.9301, valued at
$9.3k
Exercised 32,500 restricted stock units
@ $0 |
|
| 01/28/2022 |
4
| Fernandes Peter (CHIEF REGULATORY & SAFETY OFFR) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 65,000 restricted stock units
@ $0 |
|
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2019 |
4
| Fernandes Peter (Chief Regulatory & Safety Offr) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 175,500 options to buy
@ $0.5, valued at
$87.8k
|
|
| 01/04/2019 |
4
| Fernandes Peter (Chief Regulatory & Safety Offr) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $0.88, valued at
$11k
|
|
| 11/23/2018 |
4
| Fernandes Peter (Chief Regulatory & Safety Offr) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 137,500 options to buy
@ $0.91, valued at
$125.1k
|
|
| 09/27/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2018 |
4
| Fernandes Peter (Chief Regulatory & Safety Offr) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 11,304 shares
@ $2.37, valued at
$26.8k
|
|
| 01/17/2018 |
4
| Fernandes Peter (Chief Regulatory & Safety Offr) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Granted 31,527 shares
@ $0
Granted 100,000 options to buy
@ $2.03, valued at
$203k
|
|
| 01/08/2018 |
4
| Fernandes Peter (Chief Regulatory & Safety Offr) has filed a Form 4 on Bellerophon Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 35,321 shares
@ $2.49, valued at
$87.9k
|
|
| 03/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|